- Home
- HAE
as 11-14-2024 3:33pm EST
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 3.8B | IPO Year: | 1991 |
| Target Price: | $107.88 | AVG Volume (30 days): | 695.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.41 | EPS Growth: | -3.24 |
| 52 Week Low/High: | $70.25 - $97.97 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,361,223,000 | Revenue Growth: | 9.84% |
| Revenue Growth (this year): | 7.71% | Revenue Growth (next year): | 4.89% |
Latest Haemonetics Corporation News
HAE Breaking Stock News: Dive into HAE Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Labcorp Adds New Capabilities to Global Trial Connect: Stock to Gain?
Zacks
2 days ago
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
Argus Research
2 days ago
HAE: Raising target price to $98.00
Zacks
2 days ago
Here's Why Haemonetics (HAE) is a Strong Value Stock
Zacks
3 days ago
National Vision Q3 Earnings Top Estimates, Revenues Lag, Stock Tumbles
Zacks
3 days ago
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet
Zacks
4 days ago
Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand
Simply Wall St.
6 days ago
Haemonetics Second Quarter 2025 Earnings: EPS Misses Expectations
Compare HAE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HAE Haemonetics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.